Dr. Rockwell is a transplant hematologist and a member of the Bone Marrow and Stem Cell Transplant, Hematology Oncology, and Multiple Myeloma and Amyloidosis Multidisciplinary Teams at Karmanos. He specializes in bone marrow transplants and treating leukemia, lymphoma, multiple myeloma, myelodysplasia, and non-Hodgkin lymphoma. Dr. Rockwell has research and clinical interests in enhancing the efficacy of allogenic stem cell transplant and low-dose metronomic treatments to limit the toxicities of therapy.
He completed his postdoctoral fellowship in hematology and oncology at Montefiore Medical Center and the Albert Einstein College of Medicine, where he studied the role of glutaminase inhibition in resistant acute lymphoblastic anemia and detecting early signs of myeloid malignancies in first responders exposed to the World Trade Centers on Sept. 11, 2001. He also completed his residency at Montefiore, studying health-related outcomes for patients with acute leukemia. In this research, Dr. Rockwell focused on the role race and ethnicity play in survival outcomes for patients with this disease. In addition to his postdoctoral fellowship and residency work, Dr. Rockwell completed his Doctor of Medicine at the University of Toledo, College of Medicine and Life Sciences. He is board-certified by the American Board of Internal Medicine for internal medicine and hematology, and is active in the American Society of Hematology and the American Society of Clinical Oncology.